Fortrea Acquires Worldwide Clinical Trials’ Early Phase Division for $45M to Add 200-Bed CPU and GLP Bioanalytical Lab
Revelation Biosciences Selects Avance Clinical as CRO for Phase 2/3 TITAN Study of Gemini in Acute Kidney Injury Read more
Clinilabs Appoints IQVIA Veteran Laura Shannon as CEO to Lead CNS CRO Into Next Growth Phase Read more
BioCytics and LIDE Biotech Form CRO Alliance to Develop PDX Screening Platforms for Immuno-Oncology Cell Therapy Read more
Niagen Bioscience Selects Evotec as CRO to Advance IND-Enabling Development for NB4168 in Ataxia Telangiectasia Read more
South Korean CRO BNP Lab Partners With The Invention Lab to Co-Invest in Biotech Startups From Discovery to Scale-Up Read more
Clean Cells Acquires Mass Spectrometry CRO Anaquant to Deliver End-to-End Protein Characterization From Early Development Through GMP Release Read more
ICON Partners With Anthropic in Multi-Year Collaboration to Deploy Claude’s Frontier AI Across the Clinical Trial Lifecycle Read more
Quartesian Co-Founders Reunite to Launch Acrosian as a Purpose-Built AI-Native Biometrics CRO Read more
HoneyNaps Registers as CRO to Expand AI-Powered Sleep Analytics Across Global Pharmaceutical and Medical Device Trials Read more
GCCL and GemPharmatech Sign MOU to Deliver Integrated Preclinical-to-Clinical CRO Services Across Korea, U.S., and China Read more
Crown Bioscience Joins C-Path’s NAMs Developer Coalition to Advance Regulatory Acceptance of Human-Relevant CRO Preclinical Models Read more
CellCarta Launches Global Digital Pathology and AI Consortium to Give CRO Sponsors Platform-Agnostic Access to Leading AI Innovators Read more
HKeyBio Launches HKEY-AI-NAM-Bridge™ 1.0 to Close Evidence Gaps Between AI, NAMs, and In Vivo CRO Validation Read more
NetraMark Signs First CRO-Channelled Contract to Apply NetraAI Platform to Phase 2 Neurodegeneration Trial Data Read more
ProPharma Deploys Proprietary AI Capability to Accelerate ANDA Submission Development for Regulatory CRO Clients Read more
CNR Research Posts Record CRO Order Backlog as Overseas Contracts and AI Platform Transition Drive Growth Read more